We observed that tumors did not induce significant changes on the phenotype of senescent T cells; however, some molecular programs related to DNA reparation, T-cell costimulation markers or oncogene-induced senescence were modified in DP CD4+ T cells from BC patients compared to HDs, suggesting that signals derived from tumors may influence certain biological functions of this T cell subset. Here, CD4 is linked to breast cancer.